Yasumasa Ikeda

4.4k citations
151 papers · 3.5k indexed · h-index 34

Yasumasa Ikeda

147 papers receiving 3.5k citations

Peers

Yasumasa Ikeda
Comparison fields: 5 of 125
  • Hematology 439
  • Nephrology 228
  • Cardiology and Cardiovascular Medicine 584
  • Genetics 270
  • Endocrinology, Diabetes and Metabolism 412
Replace Franco Dallegri with:
Franco Dallegri Italy
Anthony J. Valente United States
Jan Philippé Belgium
Elsa Sánchez‐López Spain
Elena Galkina United States
Hidemi Yoshida Japan
Pierré Sirois Canada
Laurent Yvan‐Charvet United States
Barry J. Potter United States
Luis Miguel Blanco‐Colio Spain
Yasumasa Ikeda relative to Franco Dallegri Italy Franco Dallegri's profile →
Citations per field
00.5×1.5×1.8×
Franco Dallegri · 1×
Citations per year

Countries citing papers authored by Yasumasa Ikeda

Since Specialization
Citations

This map shows the geographic impact of Yasumasa Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasumasa Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasumasa Ikeda more than expected).

Fields of papers citing papers by Yasumasa Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasumasa Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasumasa Ikeda. The network helps show where Yasumasa Ikeda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yasumasa Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yasumasa Ikeda Line = papers co-authored together Yasumasa Ikeda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20234
4 202322
5 20215
6 20218
7 20212
8 202012
9 201926
10 201829
11 201815
12 201726
13 20145
14 201350
15 20116
16 20106
17 20094
18 200940
19 200111
20 199634

About Yasumasa Ikeda

Yasumasa Ikeda is a scholar working on Hematology, Nephrology and Cardiology and Cardiovascular Medicine, having authored 151 papers that have together received 3.5k indexed citations. Recurring topics across this work include Iron Metabolism and Disorders (14 papers), Nitric Oxide and Endothelin Effects (12 papers), Hemoglobinopathies and Related Disorders (10 papers), Adipokines, Inflammation, and Metabolic Diseases (10 papers), Cancer, Hypoxia, and Metabolism (10 papers), Renin-Angiotensin System Studies (9 papers), Chronic Kidney Disease and Diabetes (9 papers) and Electron Spin Resonance Studies (7 papers). The work is most often cited by research in Hematology (439 citations), Nephrology (228 citations) and Cardiology and Cardiovascular Medicine (584 citations). Yasumasa Ikeda has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshiaki Tamaki, Koichiro Tsuchiya, Ken‐ichi Aihara, Yoshitaka Kihira, Keisuke Ishizawa, Yuki Izawa‐Ishizawa, Toshio Matsumoto, Masashi Akaike, Shuhei Tomita and Yuya Horinouchi. Their work appears in journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026